What is NDC 11673-192?

11673-192 is the product NDC for Stool Softening Senna Laxative, Docusate sodium 50 mg/1; Sennosides a and b 8.6 mg/1 tablet, listed with the FDA by TARGET CORPORATION. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Stool Softening Senna Laxative (Sennosides 8.6 mg - docusate sodium 50 mg).

What is the active ingredient?

Docusate sodium, Sennosides a and b.

TARGET CORPORATION, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Stool Softening Senna Laxative?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Stool Softening Senna Laxative NDC 11673-192

NDC codes

FDA NDC Directory

Product NDC (as listed)11673-192Labeler and product segments. Claims need a package NDC.

Product NDC at billing width11673-0192Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
11673-192-03	1167301920311673019203	30 TABLET in 1 BOTTLE (11673-192-03)Marketed from Mar 29, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Stool Softening Senna Laxative
Generic name (nonproprietary): sennosides 8.6 mg - docusate sodium 50 mg
Active ingredients: Docusate sodium — 50 mg/1Sennosides a and b — 8.6 mg/1
Dosage form: Tablet
Route: Oral
Labeler: TARGET CORPORATIONNDC labeler code 11673
Product type: Over-the-counter drug
Marketing category: OTC monograph (not final)Application part334
Marketing start: Mar 29, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 11673-192_81f51705-1b12-f726-e053-2991aa0a8e02SPL ID 81f51705-1b12-f726-e053-2991aa0a8e02SPL set ID 7c74bd91-6687-2b89-e053-2a91aa0ad6b8RxCUI 998740UNII F05Q2T2JA0, 1B5FPI42ENUPC 0349483081039

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N411673019203 followed by a unit qualifier and the quantity

Package 11673-0192-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Relieves occasional constipation (irregularity); generally causes a bowel movement in 6-12 hours

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 11673-192

What is NDC 11673-192?: 11673-192 is the product NDC for Stool Softening Senna Laxative, Docusate sodium 50 mg/1; Sennosides a and b 8.6 mg/1 tablet, listed with the FDA by TARGET CORPORATION. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Stool Softening Senna Laxative (Sennosides 8.6 mg - docusate sodium 50 mg).
What is the active ingredient?: Docusate sodium, Sennosides a and b.
Who is the labeler?: TARGET CORPORATION, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Stool Softening Senna Laxative?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under part334

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under part334
Product	Strength	Form · route	Labeler	Product NDC
Docusate Sodium	Docusate sodium 100 mg/1	Capsule, Liquid filledOral	Preferred Pharmaceuticals Inc.	68788-8658
Freds Saline Twin Pack Laxativesodium phosphate, dibasic, unspecified form and sodium phosphate, monobasic, unspecified form	Sodium phosphate, Dibasic, Unspecified form 7 g/133mL; Sodium phosphate, Monobasic, Unspecified form 19 g/133mL	EnemaRectal	FRED'S	55315-301
Marcs Twin Packsodium phosphate, dibasic, unspecified form and sodium phosphate, monobasic, unspecified form	Sodium phosphate, Dibasic, Unspecified form 19 g/133mL; Sodium phosphate, Monobasic, Unspecified form 7 g/133mL	EnemaRectal	Marc Glassman Inc.	68998-233
Pro-Enema Single Saline Laxativesodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form	Sodium phosphate, Dibasic 7 g/118mL; Sodium phosphate, Monobasic, Unspecified form 19 g/118mL	EnemaRectal	Propharma Medical Supplies	71451-001
Quality Choice Single Saline Laxativesodium phosphate, dibasic, unspecified form and sodium phosphate, monobasic, unspecified form	Sodium phosphate, Dibasic, Unspecified form 7 g/118mL; Sodium phosphate, Monobasic, Unspecified form 19 g/118mL	EnemaRectal	Alcyon Health, LLC.	71443-001
Saline Laxative Cherry Laxativesodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form	Sodium phosphate, Dibasic 2.7 g/45mL; Sodium phosphate, Monobasic, Unspecified form 7.2 g/45mL	LiquidOral	Dolgencorp Inc.	55910-339
Stimulant Laxativebisacodyl	Bisacodyl 5 mg/1	Tablet, Delayed releaseOral	TIME CAP LABORATORIES, INC.	49483-003
Stimulant Laxative Plus Stool Softenerdocusate sodium 50 mg and sennosides 8.6 mg	Sennosides 8.6 mg/1; Docusate sodium 50 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals, Inc.	68788-7674
Womens Gentle Laxativebisacodyl	Bisacodyl 5 mg/1	TabletOral	TARGET CORPORATION	11673-151